The materials include pet owner guides, reception posters and slides to display on waiting room TV.
They complement the Krka veterinary professional guide on responsible risk-based parasiticide use for cats and dogs that was developed in conjunction with Ian Wright BVMS MSc MRCVS and launched last year.
Renzo Di Florio, Krka’s Technical Veterinary Adviser said: “In first opinion veterinary practice, where the majority of consultations last 15 minutes or less, time is short and in-depth discussions are not always possible.
"The guides provide comprehensive information on common parasites, practical advice on prevention and treatment and information on risk assessment.
"And by aligning with ESCCAP guidelines, the guides help address the delicate balance between animal health, human health and environmental protection – a true One Health issue.”
https://www.krka.co.uk/veterinary-knowledge-hub/articles/risk-based-parasiticide-use-for-cats-and-dogs
The Clinical Abstracts provide an opportunity to present new research to the wider veterinary community at Congress and Expo 2025, taking place at Manchester Central on 20th - 22nd March 2025.
Abstracts can be on any veterinary subject, whether it’s the preliminary results of a new study, a discussion of a new technique or a description of an interesting case.
Each application should be based on high-quality clinical research undertaken in industry, practice or academia, and summarised in 250 words.
Applications are welcome from veterinary surgeons, nurses, practice managers and students, with applications from those working in general practice especially encouraged.
Researchers with research of direct relevance to veterinary practice may also submit an abstract for consideration.
Andy Green, Chair of BSAVA’s Congress Committee said: “This is a fantastic opportunity for veterinary professionals to showcase their research to the global veterinary community, and a chance for delegates to learn about the latest concepts and thinkings in veterinary medicine from their peers.”
Entries for the Clinical Abstracts will close on Monday 18th November.
https://www.bsavacongress.com/clinical-abstracts
For the study, the RVC interviewed 13 small animal general practitioners, exploring their experience of providing pre-purchase consultations for brachycephalic dogs.
The study revealed a number of barriers to delivering effective pre-purchase consultations and advice about these breeds.
They included limited time and resources, competition for appointment availability, a perception that vets are only there to fix things, public distrust of veterinary surgeons (often over money), fear of damaging vet-client relationships, and the conflicting influence of breeders and the Kennel Club on clients.
Many veterinary surgeons that took part in the research felt that they had little or no power to overcome these barriers which are highly intractable at an individual veterinarian level.
A resulting moral conflict in veterinary surgeons between their perceived ethical and moral responsibilities to animal welfare versus the needs and wants of their clients and businesses was expressed by many vets in the study, and was felt to compromise their professional integrity and autonomy.
The study set out a series of recommendations:
Dr Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science at the RVC and lead author of the study, said: “This is the first time that the impact of brachycephaly on the practising veterinary surgeon has been explored.
"Our concerning results highlight the importance of recognising that the brachycephalic crisis is not only negatively impacting animals, but it is affecting human wellbeing too.
“Our study highlights the conflict that vets are experiencing - bound both by their duty of care to their brachycephalic patients, but also to animal welfare at a population level.
"Trying to balance both of these responsibilities in the current working environment is proving very challenging for some, leading to moral distress.
"It is, therefore, essential that we protect the mental wellbeing of vets on this issue as well as from an animal welfare perspective.
“As the brachycephalic crisis continues to prevail, the support of leading veterinary organisations is vital in providing a united voice regarding the known harms of brachycephaly and support in facilitating PPCs to ensure vets are protected, and potential owners are fully informed when it comes to acquiring decisions.”
Dr Dan O’Neill, Assoc Prof of Companion Animal Epidemiology at the RVC and co-author of the study, said:
“Over the past decade, the RVC has generated a vast evidence base revealing the true extent of the serious health issues of dogs with brachycephaly.
"This new study now focuses RVC research towards protecting the wellbeing of practising veterinary surgeons who are also shown as victims of the brachycephalic crisis.
"The clear message here is that we all need to ‘stop and think before buying a flat-faced dog’.”
All RVNs were set an email with a voting link and a unique voter code.
The College says it will be writing to the few veterinary nurses for whom it has no unique email address with further instructions.
There are 3 candidates standing this year and you can now cast your votes for up to two of them by 5pm on Friday 26 April 2024.
The candidates are:
The individual candidate profiles are available to view at www.rcvs.org.uk/vnvote24 where you can also read the candidates’ answers to two questions of their choice submitted by the profession.
The two candidates with the most votes will join VN Council for their three-year terms at the College’s AGM in July.
Any vet nurses who have not received their voting email should contact CES directly on support@cesvotes.com.
The ERP was established in 2016 when it emerged that an increasing number of research projects were being conducted in private veterinary practices. In these settings, researchers may not always be familiar with the regulations and the ethical best practice needed for clinical veterinary research.
The ERP reviews both prospective and retrospective research projects on cats, dogs, horses and farm animals. As well as reviewing animal-based research, the panel also reviews sociological studies involving veterinary staff.
There are currently seven available spaces on the panel, and the RCVS is looking to fill the spaces with:
The Panel is Chaired by Professor David Morton, who said: “I’ve been honoured to Chair the Ethics Review Panel for the last five years. Through my role as Chair, I have had the opportunity to work alongside some exceptional veterinary professionals and I encourage anyone with a keen interest in clinical veterinary research to apply for a position on the Panel.”
To apply, visit www.rcvs.org.uk/ethics-panel and send a completed application form and CV to ethics@rcvs.org.uk.
The deadline for applications is 5pm on Friday 16 July 2021.
The company says that Daxocox achieves significant improvement of clinical signs associated with the pain of osteoarthritis (OA) in dogs1,2 and also helps reduce the risk of breakthrough pain.
Breakthrough pain is defined as “an abrupt, short-lived, and intense pain that breaks through the analgesia that controls pain”3. Risk factors for breakthrough pain in cases of canine OA include poor owner compliance, variable plasma drug levels between doses, natural or exercise induced flare-ups and disease progression.
According to research carried out by the company, veterinary surgeons estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain4, whilst owners put the figure much higher at 80%5.
Animalcare says that as well as compromising patient welfare and increasing the risk of clinical consequences such as wind-up pain (hypersensitisation), breakthrough pain risks owners losing confidence in their vet and/or the recommended treatment plan for their dog. This may lead owners to independently stray from the treatment plan, with potentially damaging consequences. In its research, 87% of vets agreed that avoiding breakthrough pain is critical to the management of canine OA4.
Animalcare adds that because of the pharmacology, there is no risk of risk of over-accumulation or need for mandatory treatment ‘breaks’6. Also, adverse effects were found to be no different from any other NSAID1,2 and there was no increase in treatment-related adverse effects at up to 5 times the recommended dose7, so Daxocox has a broad margin of safety and is well tolerated by dogs7.
James Beaumont, marketing manager at Animalcare said: “Daxocox’s weekly administration of a flavoured tablet addresses some of the challenges of managing canine OA that I’m certain most vets will identify with. Breakthrough pain is a real problem and by being able to provide consistent pain control, in a compliance friendly formulation, Daxocox is a real game changer for canine OA management.
For more information, visit: www.animalcare.co.uk, or contact your local Animalcare territory manager, or Animalcare’s head office on 01904 487687.
References:
The clinic will be led by Oscar Bautista MRCVS (pictured), a European Specialist in Veterinary Anaesthesia and Analgesia.
It will offer an individualised approach for patients with chronic pain (such as osteoarthritis, neck, back and facial pain) and those suffering nerve or muscular pathologies, cancer pain, neuropathic pain or pain associated with certain neurological conditions.
Treatments may include adjustments to medications, acupuncture, lifestyle modifications or referrals to other Specialists and therapists.
Oscar said: “Many cats and dogs will experience pain - especially as many animals are now living longer. And we are aware that some cases can be very challenging to diagnose and treat, when both the local vet and owner have attempted various different therapies and are getting desperate.
“These difficult cases need to be thoroughly investigated to ensure that the cause of pain is properly identified and the right treatment provided - as instigating early management can help to reduce and regulate pain.
“So we are very pleased to be able to open our new Pain Management Clinic. With our specialist facilities and equipment - along with our depth knowledge multidisciplinary approach - we hope that it will provide an essential service for cat and dog owners in the Northwest.”
https://www.mvsvets.co.uk
The opening speaker will be Cassie Leonard (pictured), engineer, best-selling author and executive coach, who will be talking about the value of authentic networking.
The programme, which includes a combination of lectures, panel sessions and interactive workshops, will cover:
On the Saturday, there's a dedicated ‘Grow your business’ day for those thinking of starting up or expanding their business.
New for 2025 will be a Friday morning collaborative ‘Business Club Live’ speed-networking session: an opportunity to discuss a variety of issues on hosted tables.
Also new for 2025 will be a dedicated livestock stream focussing on the unique challenges faced by livestock veterinary professionals.
The accompanying exhibition will host a selection of companies focussed on the business, management, marketing and client-facing aspects of veterinary practice and offering the latest products, services and advice.
Social events include Thursday afternoon's Happy Hour followed by a networking event and Friday night’s Presidents’ party with a reception, 3-course meal and a performance by the party band The Kings.
www.spvs-congress.co.uk
Available in packs of 56 (4 x 14 tablet blister packs), Lodisure tablets are divisible for accurate dosing.
The recommended starting dose is 0.125-0.25 mg amlodipine per kg bodyweight per day, which equates to half a tablet for cats weighing less than 4kg (and more than 2kg) and one tablet per day for cats weighing between 4kg and 8kg.
It can be administered directly to the cat or given with a small quantity of food.
Dechra companion animal brand manager, Sarah Musgrave, said: “Feline hypertension is very often part of a more complex diagnosis, therefore it is important that antihypertensive therapies are easy to dose and administer.
"Lodisure is a new, first-line, easy to dose and administer treatment to control systolic blood pressure in cats while the underlying primary cause is diagnosed and treated, which vets can rely on in their day-to-day practice.”
https://www.dechra.co.uk/products/cat/prescription/lodisure.
The webinars will be available as live podcasts and will also be able to be viewed on demand on the Dechra Academy.
In the strangles webinar, Dave Rendle, Gayle Hallowell and Richard Newton will explore the current landscape of strangles control, focusing on the role of vaccination, testing and quarantine measures.
In the disease prevention webinar, Gayle Hallowell, Dave Rendle, Tamzin Furtado and others will give an insight into chronic disease management and preventative vaccination to improve uptake and optimise treatment outcomes.
Both webinars broadcast from 8pm GMT, with a live Q&A session from 8:45pm, finishing at 9:15pm.
https://membership.elearning.vet/Dechra-equine-medicine-series.
Vetbromide is presented as a 600mg double divisible tablet for both large and small dogs, and for greater flexibility with dose titration. Tablets are blister packed for ease of storage and dispensing, with a four-year unopened shelf life.
Alongside the launch, TVM has prepared a range of product support materials, including: product guidelines, treatment and monitoring guidelines, seizure management ‘lunch and learn’ sessions, and pet owner information.
TVM has also created a free e-learning tool which takes veterinary staff through the process of diagnosing, treating and monitoring dogs with suspected epilepsy.
Will Peel, product manager at TVM said: "The addition of Vetbromide to our epilepsy range allows vets more flexibility when treating epileptic patients. To further assist vets, we are also offering a wide range of free literature and in-practice support to ensure that veterinary staff are up to speed on such a common, yet at times complicated, topic.’
For more information, visit www.tvm-uk.com/epilepsy, or contact your TVM UK Territory Manager.
The streams for veterinary nurses will include six lectures on topics ranging from neurology to dentistry, along with guest speaker Hannah Donovan from Donovan Veterinary Behaviour to discuss behaviour in practice.
There will also be a speaker from Davies’ charity of the year: Vetlife.
Davies' hospital director Ben Orton said: “This is a high-level CPD and networking event aimed at our colleagues in the veterinary industry with a raft of advice and insight from some of the leading specialists here at Davies.
“Some of the topics covered include internal medicine, with EBVS European specialist in small animal internal medicine Katherine Clarke giving her expert opinion on chronic enteropathies with a focus on antibiotic prescribing.
“Head of anaesthesia Frances Downing will focus on anaesthesia and feline cardiomyopathies while head of physiotherapy Diane Messum will discuss a holistic approach to the osteoarthritis patient, so there will be plenty of stimulating and challenging content.”
The day-long event begins at 8.30am with arrival drinks and pastries before the morning session, which runs from 9am to 1.20pm.'
After an hour’s break for lunch and networking, the afternoon session will run from 2.20pm to 5pm.
That will be followed by a complimentary hog roast.
www.vetspecialists.co.uk/davies-congress-2024
Amanda originally studied and worked in Australia where she undertook a residency in small animal medicine at Murdoch University, completing a Masters in respiratory medicine in dogs.
She moved to the UK in 2016 to work in referral medicine, joining Hamilton Specialist Referrals in 2024 as head of its medicine service.
The webinar will include a refresher on the bacterial, fungal, parasitic and protozoal causes of lower respiratory tract disease and its pathology, after which it will look at techniques and methods for diagnosis.
Amanda's presentation will also look at the secondary effects of infectious lower respiratory disease pathogens, and prescribing and management options.
The webinar is open to vets, veterinary nurses, students and support staff.
https://horiba.link/respiratory-disease-in-dogs-and-cats
Rowe Referrals, part of IVC Evidensia Referrals, was one of the very first practices to have an onsite MRI when it installed a 1.5T model five years ago. Now, thanks to investment from IVC Evidensia - of which it is a part - Rowe has been able to replace the ageing model with a new 3.0T machine, which will enable clinicians to diagnose and implement treatment plans quicker.
Referrals Manager at Rowe Referrals, Meg Hayman, said: "The difference between the two machines in amazing. The 1.5T produced very detailed scans but the 3.0T is incredible! It gives our clinicians the ability to perform more complex investigations with far greater clarity.
The practice says benefits will be seen across all disciplines, including neurology, internal medicine, ophthalmology, dentistry, orthopaedics and soft tissue.
Ian Jennings BSc BVSc CertVDI MRCVS RCVS Advanced Practitioner in Diagnostic Imaging said: "The new 3.0T MRI scanner allows us a much more detailed view of our patients, and has been especially useful for detection of smaller lesions in our neurological and orthopaedic cases. Specialised sequences can also be performed in less time, allowing us a greater ability to help more patients."
The nursing stream will run all day on Friday 13 September and not only will there be a dedicated lecture and workshop stream but there will also be practical sessions on critical care and bandaging, casting and suturing.
In the critical care session, nurses will be able to problem solve and carry out nursing tasks on a variety of models to simulate treating real life critical care cases.
In the bandaging, casting and suturing practical, nurses will be immersed in a learning experience where they can showcase their existing skills and learn new ones.
The nursing stream also includes a neurodiversity workshop which is open to all.
Marie Rippingale, BEVA’s Equine Veterinary Nurse Committee Chair, said “All in all - this Congress nursing stream is not to be missed!
"It is a perfect balance of theory and practical sessions run by friendly and approachable experts in their field who are keen to share their knowledge and experience for the benefit of the equine nursing profession.”
Tickets are £221 for all three days for BEVA nurse members.
Day tickets and practice passes are also available.
http://www.bevacongress.org
The company points to research which shows that osteoarthritis can affect up to 40% of dogs 1,2 and managing the disease requires a multi-faceted 1,3, life-long, approach.
Animalcare says its osteoarthritis diary gives practices a practical, client-friendly tool to engage pet owners in their dog’s care journey, promoting adherence to treatment plans and enhancing communication between vets and pet owners.
Pet owners are asked to record three everyday activities to monitor their dog's progress, for example, its ability to get into the car, go upstairs or get up after sleeping, on a scale of 1-4.
This will allow all members of the veterinary team to understand how the patient is responding to treatment.
Kai Crawshaw, Brand Manager at Animalcare said: “This OA Diary is intended to enhance the veterinary practice’s ability to offer comprehensive, contextualised care, without increasing their workload.
"The diary supports both initial treatment plans and long-term management strategies, giving veterinary staff confidence that their patients are receiving the ongoing care they need at home.”
https://www.animalcare.co.uk/oa_diary/
References
Four new procedures have been added: cystostomy tube placement, endotracheal intubation, point-of-care ultrasound (POCUS), and wet-to-dry dressings.
The new video content, access to which is included with the printed book, has been designed as a ‘go to’ resource to reference prior to performing a procedure.
Nick Bexfield, one of the editors of the new edition, said: “We have built upon the success of the previous editions by responding to the feedback received from the BSAVA readership, and hope this new guide helps to further increase the confidence and accuracy with which these procedures are performed.”
Print copies are available through the BSAVA store, you can also access the digital version in the BSAVA Library.
Prices are £45.50 for BSAVA members; £70.00 for non-members.
At the meeting, Simon Biles from Moore Scarrott gave a 30 minute presentation, which was followed by a one hour discussion.
The recording can be watched on VetNurse.co.uk here https://www.vetnurse.co.uk/001/nonclinical/m/meetings/156693, where you can also claim the time watching towards your annual CPD requirement. Press the 'Claim CPD' red button in the title bar towards the top.
To make it easier to find content that interests you, there are markers on the video timeline.
There is also a forum thread on vetsurgeon.org for further discussion of any of the points raised in the film. See: https://www.vetnurse.co.uk/001/nonclinical/f/vetnurse-site-support/32174/vetnurse-zoom-ir35-locums-umbrella-companies-and-corporates/177103#177103
For more information about Moore Scarrott, visit: https://www.moore-scarrott.co.uk
The first, hosted by Sam Taylor, head of veterinary specialists at ISFM (International Society of Feline Medicine) is titled ‘Whetting the appetite: purr-fectly feeding your knowledge of feline inappetence and why early detection shouldn’t be overlooked’.
The session, which starts at 12:30pm on Tuesday 6th, will explore the importance of feline inappetence, how it goes overlooked by owners and practices alike and why it shouldn’t be underestimated.
In the second session, which starts at 12:30pm on Friday 9th, Libby Koytzoumis, veterinary technical advisor at Dechra (pictured), will talk about one of the most commonly diagnosed endocrine diseases in dogs, Cushing’s syndrome.
Libby's webinar, ‘Are you seeing these usual suspects in practice?’ will explore the common signs, routes to diagnosis and the effective treatment and monitoring of Cushing’s.
https://thewebinarvet.com/events/virtual-veterinary-congress-2024
The HT Vista device measures heat transfer rate differences between masses and adjacent normal tissues and then processes that data using machine learning algorithms to classify the masses.
The study evaluated a diverse canine population of 299 dogs with 525 cutaneous and subcutaneous masses.
In the study, the device correctly classified 45 out of 53 malignant masses and 253 out of 378 benign masses (sensitivity = 85% and specificity = 67%).
The negative predictive value of the system (i.e., percent of benign masses identified as benign) was 97%.
This study concluded that the data supports the use of the HT Vista device "as a screening tool and decision support tool for the everyday diagnosis of dermal and subcutaneous masses in general practice, enabling clinicians to differentiate between benign lesions and those requiring additional diagnostics".
Liron Levy-Hirsch, Managing Director of HT Vista’s UK subsidiary said: “We are thrilled to have scientific research validating the success of the HT Vista device.
"The veterinary teams who have already adopted the device into their practice are having great success with it, and with the backing of this newly published paper we hope to reach more practices and ultimately save more dog’s lives.”
www.ht-vet.com / www.ht-vista.uk
Reference
The RCVS says this is the first time that two leading organisations in veterinary QI are collaborating to establish a new evidence-based model for QI specific to veterinary care.
The project is being overseen by Jocelyn Toner MRCVS, an experienced veterinary surgeon with a background in shelter medicine and an interest in evidence-based interventions to improve welfare outcomes.
The team will test the model against a prevalent problem in practice and measure the cost of making the changes against the benefit it brings.
They will refine the model based on lessons learned before they make it available to all veterinary practices, to tackle any area a practice wants to improve, regardless of practice type or specialism.
The aim is to help time-poor practitioners implement proven QI methods to improve outcomes and provide a return on investment.
Jocelyn said: “I’m looking forward to working with colleagues from across the sector to develop a model that will make Quality Improvement more accessible, and show that it can have a real economic benefit.
"We know that there is increased demand for veterinary teams to provide more efficient and effective care while maintaining high levels of animal welfare, improving team welfare and client satisfaction.
"Over recent years an increasing number of veterinary teams have embraced QI techniques.
"Now is the time to take this to the next level by creating an evidence-based model for QI, which can be applied systematically in any veterinary setting.
The project will involve bringing together veterinary professionals to co-design the model and test it in practice.
If you are interested in supporting this work, please register your interest at: rcvsknowledge.org.uk/forms/ktp-interest-form/
The judges praised the practice group for leveraging employee ownership (EO) to drive growth and staff satisfaction, protect independence, and champion EO in the veterinary sector.
Pennard Vets, which has eight practices in Kent, says its driving ambition when it took the decision to transfer the business into an employee ownership trust and make its 150-strong team business owners, was to protect its independence and core values.
Pennard Vets has also been eager to spread the word about employee ownership to other veterinary practices.
Matthew Flann, a director from Pennard Vets, said: “Winning this award is a huge coup for our entire industry, who have been searching for ways to secure the future of their independent practices.
"Set against a backdrop of increasing corporatisation of UK veterinary practices, we chose to protect our heritage by becoming an EOT.
“It hasn't been easy, but it has been massively rewarding and our team have passionately bought into their new status as owners, and the results can be seen throughout the practice – from team-led initiatives to the impact on the range of procedures we can now offer to our patients.
"It’s genuinely been transformational and since 2021 we’ve doubled turnover and grown our team by 30%.
"We’ve also welcomed Abbotsley Veterinary Group and Priory Lodge into the group with the two local Kent practices citing our EOT status as a motivating factor for their moves.
“Crucially our EOT structure provided the launchpad to becoming the first veterinary practice in Europe to achieve B-Corp status in 2022, which we see as another step towards becoming the very best practice possible, using input and ideas from our team to provide a better service, give back to our community and protect the environment.
“We’re also determined to make the journey less arduous for other veterinary practices to follow our lead and we regularly hear from practice owners who are exploring becoming EO.
"We’ve established the British Veterinary Employee Owned Association to help guide other practices through the journey of becoming an EOT by networking, attending events and presenting webinars.
"This year we have supported thriving practices to become EO in all parts of the UK, including Arrowfield Vets in Herefordshire, Animal Tails Veterinary Practice in Stirling, Shetland Vets and Cornerstone Veterinary Clinic in Belfast.
“We believe intrinsically in the value of supporting and promoting our team as the best way to grow our business and provide the best possible service to our clients and patients, and that same approach will pay dividends for other veterinary practices. Because of this we fully intend to continue to campaign for the benefits of EO.”
James de le Vingne, CEO of the EOA, said: “Congratulation to Pennard Vets on winning this award.
"The awards recognise businesses and individuals that are delivering great employee ownership. Collectively, great employee owned businesses deliver significant uplift in productivity and performance, outperforming their non-EO counterparts across multiple impacts for employees, society, the environment and the economy.”
The award categories are:
Nominations are welcome from both BSAVA members and non-members.
Nominations close on 30th October 2024 and the winners will be announced on 16th January 2025.
The BSAVA awards ceremony will take place at the reinvented Congress and Expo 2025, taking place at Manchester Central in March.
https://www.bsava.com/awards.
Whilst you're there, the company will doubtless use the opportunity to bend your ear about how its technology can save time, drive revenue, and strengthen patient care.
Still, all in a good cause, and the company says it expects to be making a significant donation towards supporting members of the veterinary community who are experiencing financial and mental health challenges.
ezyVet Chief Growth Officer Pete Brown said: ““As innovators in the veterinary software space, we’re passionate about bettering the lives of veterinary professionals and we recognise the critical work Vetlife is doing to support the hard-working veterinary community.
"We’re going to be donating £1 to Vetlife for every person that visits the ezyVet booth at the London Vet Show, so we encourage everyone to come down and help us support this very worthwhile cause.”
Congress offers two days of lectures and workshops and up to 14 hours CPD delivered by experts on the most cutting-edge OA management, treatment, techniques and technology.
There is also a large trade exhibition showcasing many of the latest products and services, not to mention a happy hour and gala dinner.
The organisers say veterinary surgeons and nurses, physiotherapists, hydrotherapists, and anyone working to prevent, treat and manage osteoarthritis will find the congress hugely rewarding.
This year there’s a focus on comparative disciplines, including human and equine practice.
Tickets cost from £190 to £370, plus VAT.
www.vet-oa.com/voacon